Search results for "Marijuana Abuse"

showing 10 items of 16 documents

Alcohol and Cannabis Intake in Nursing Students

2019

Background and objectives: Drug misuse among young people has become a major worldwide health concern. The present study analyzes substance misuse and its social and personal consequences in young university students. Materials and Methods: Screening of alcohol misuse was based on the Alcohol Use Disorder Identification Test (AUDIT), while screening of substance-related risks and problems was performed with the Car, Relax, Alone, Forget, Friends, Trouble (CRAFFT) score. Results: The population was composed of nursing students at the University of Valencia (Valencia, Spain) (n = 185). More than 50% of the surveyed students reported alcohol intake based on the CRAFFT scale

AdultMaleMarijuana AbuseMedicine (General)Alcohol DrinkingSubstance-Related Disordersalcohol abusealcohol abuse; marijuana; social consequences; CRAFFT scale; audit scalePopulationProtective factorAlcohol abuseAuditHashishLogistic regressionArticleYoung AdultSex FactorsR5-920NursingSurveys and QuestionnairesmedicineHumanseducationeducation.field_of_studyAlcohol Use Disorders Identification Testbiologybusiness.industryAge FactorsGeneral Medicineaudit scaleMiddle Agedbiology.organism_classificationmedicine.diseaseAlcoholismLogistic ModelsSpainsocial consequencesFemaleMarijuana UseStudents NursingCannabisbusinessCRAFFT scalemarijuanamedicine.drugMedicina
researchProduct

Age of onset of Cannabis use and cognitive function in first-episode non-affective psychosis patients: Outcome at three-year follow-up

2018

In recent years, the effects of cannabis use on cognitive functions in patients with psychosis have been widely studied. Recently, special emphasis has been placed on the impact of age at the onset of consumption on cognition in these patients.349 patients with a first episode of non-affective psychosis were studied. Patients were classified as cannabis users and non-users. Users were divided, according to their age when they began using cannabis, into: early-onset (age  16) and late-onset (age ≥ 16) users. Differences between groups at baseline were studied based on sociodemographic, clinical, and cognitive variables. The groups were longitudinally (3-year) compared on cognitive variables.…

AdultMaleMarijuana AbusePsychosismedicine.medical_specialty030508 substance abuseYoung Adult03 medical and health sciencesCognition0302 clinical medicineMemoryHumansMedicineLongitudinal StudiesAge of OnsetPsychiatryBiological PsychiatryEffects of cannabisFirst episodebiologybusiness.industryCognitionbiology.organism_classificationmedicine.diseasePsychiatry and Mental healthCross-Sectional StudiesPsychotic DisordersDisease ProgressionSpeech PerceptionFemaleMarijuana UseCannabisVerbal memoryAge of onset0305 other medical sciencebusinessNeurocognitive030217 neurology & neurosurgeryFollow-Up StudiesSchizophrenia Research
researchProduct

Prevalence of bullying victimisation amongst first-episode psychosis patients and unaffected controls

2013

Background—Despite increasing evidence suggesting that childhood maltreatment is significantly associated with psychosis, the specific role of bullying in the onset of psychotic disorders is still unclear. This study aimed to examine whether bullying was more prevalent amongst individuals presenting to services for the first time with a psychotic disorder than in unaffected community controls. Methods—Data on exposure to bullying, psychotic symptoms, cannabis use and history of conduct disorder were collected cross-sectionally from 222 first-presentation psychosis cases and 215 geographically-matched controls. Bullying victimisation was assessed retrospectively as part of the Brief Life Eve…

AdultMaleMarijuana AbusePsychosismedicine.medical_specialtyAdolescentPoison controlPsychosiVictimisationArticleOccupational safety and healthYoung AdultRisk FactorsSurveys and QuestionnairesInjury preventionPrevalencemedicineHumansYoung adultFirst episodePsychiatryCrime VictimsBiological PsychiatryRetrospective StudiesPsychiatric Status Rating ScalesFirst episodeBullyingmedicine.diseasePsychiatry and Mental healthPsychotic DisordersSchizophreniaSchizophreniaVictimisationFemalePsychologyBullying; First episode; Psychosis; Schizophrenia; VictimisationClinical psychologySchizophrenia Research
researchProduct

Confirmation that the AKT1 (rs2494732) genotype influences the risk of psychosis in cannabis users.

2012

Background Cannabis use is associated with an increased risk of psychosis. One study has suggested that genetic variation in the AKT1 gene might influence this effect. Methods In a case-control study of 489 first-episode psychosis patients and 278 control subjects, we investigated the interaction between variation at the AKT1 rs2494732 single nucleotide polymorphism and cannabis use in increasing the risk of psychosis. Results The rs2494732 locus was not associated with an increased risk of a psychotic disorder, with lifetime cannabis use, or with frequency of use. We did, however, find that the effect of lifetime cannabis use on risk of psychosis was significantly influenced by the rs24947…

AdultMalemedicine.medical_specialtyPsychosisMarijuana AbuseEpisode of CarePolymorphism Single NucleotideRisk AssessmentOddsInternational Classification of DiseasesRisk FactorsLondonSettore MED/48 -Scienze Infermierist. e Tecn. Neuro-Psichiatriche e Riabilitat.medicineConfidence IntervalsOdds RatioHumansGenetic Predisposition to DiseaseGenetic TestingGene–environment interactionPsychiatrySettore MED/25 - PsichiatriaBiological PsychiatryDemographybiologyCase-control studyOdds ratiomedicine.diseasebiology.organism_classificationConfidence intervalPsychotic DisordersSocioeconomic FactorsCase-Control StudiesFemaleGene-Environment InteractionAKT1 gene cannabis use gene environment interaction psychosis schizophrenia signaling pathwaysCannabisRisk assessmentPsychologyProto-Oncogene Proteins c-aktDemographyBiological psychiatry
researchProduct

Cannabis users have higher premorbid IQ than other patients with first onset psychosis.

2013

Background: A number of studies have reported that patients with psychosis who use cannabis have better cognitive performance than those who do not. This is surprising as cannabis can impair cognition in healthy subjects. An obvious question is whether the better current performance of psychotic patients who have used cannabis is a reflection of their having a higher premorbid IQ than those psychotic patients who haven't used cannabis. Aim: In a sample of patients at their first episode of psychosis, we tested the hypothesis that patients who smoked cannabis would have a higher premorbid IQ than patients who did not. Methodology: 279 participants (119 patients and 160 healthy controls) were…

AdultMalemedicine.medical_specialtyPsychosisMarijuana AbuseFirst Episode of Psychosis (FEP)Premorbid IQIntelligenceNeuropsychological TestsSubstance usebehavioral disciplines and activitiesYoung AdultCognitionSettore M-PSI/08 - Psicologia Clinicamental disordersmedicineHumansEffects of sleep deprivation on cognitive performanceCannabiYoung adultCannabis; Cognition; First Episode of Psychosis (FEP); IQ; Premorbid IQ; Risk of psychosis; Schizophrenia; Substance useRisk of psychosiPsychiatryBiological PsychiatryFirst episodeIntelligence TestsPsychiatric Status Rating ScalesAnalysis of VarianceChi-Square DistributionIntelligence quotientbiologymedicine.diseasebiology.organism_classificationPsychiatry and Mental healthPsychotic DisordersSchizophreniaIQSchizophreniaFemaleCannabisPsychologyhuman activitiesChi-squared distributionClinical psychology
researchProduct

Detection of  9-Tetrahydrocannabinol and Amphetamine-Type Stimulants in Oral Fluid Using the Rapid Stat  Point-of-Collection Drug-Testing Device

2010

The Rapid Stat assay, a point-of-collection drug-testing device for detection of amphetamines, cannabinoids, cocaine, opiates, methadone, and benzodiazepines in oral fluid, was evaluated for cannabis and amphetamine-type stimulants. The Rapid Stat tests (n = 134) were applied by police officers in routine traffic checks. Oral fluid and blood samples were analyzed using gas chromatography-mass spectrometry (GC-MS) for Delta(9)-tetrahydrocannabinol, amphetamine, methamphetamine, methylenedioxymethamphetamine, methylenedioxyethylamphetamine, and methylenedioxyamphetamine. The comparison of GC-MS analysis of oral fluid with the Rapid Stat results for cannabis showed a sensitivity of 85%, a spec…

DrugMarijuana AbuseSalivaN-Methyl-34-methylenedioxyamphetamineHealth Toxicology and Mutagenesismedia_common.quotation_subjectmedicine.medical_treatmentAmphetamine-Related DisordersPharmacologyToxicologySensitivity and SpecificityGas Chromatography-Mass SpectrometryMethamphetamineAnalytical ChemistryPredictive Value of TestsmedicineHumansEnvironmental ChemistryFalse Positive ReactionsDronabinolSalivaAmphetamineFalse Negative Reactionsmedia_commonImmunoassayChemical Health and SafetyChromatographybiologyChemistryAmphetaminesSolid Phase ExtractionMethamphetaminebiology.organism_classificationSubstance Abuse DetectionAmphetamineCannabinoidCannabisGas chromatography–mass spectrometrymedicine.drugMethadoneJournal of Analytical Toxicology
researchProduct

Prenatal exposure to the CB1 receptor agonist WIN 55,212-2 causes learning disruption associated with impaired cortical NMDA receptor function and em…

2005

The aim of this study was to investigate whether prenatal exposure to the cannabinoid CB1 receptor agonist WIN 55,212-2 (WIN) at a daily dose devoid of overt signs of toxicity and/or gross malformations (0.5 mg/kg, gestation days 5-20), influences cortical glutamatergic neurotransmission, learning and emotional reactivity in rat offspring. Basal and K+-evoked extracellular glutamate levels were significantly lower in cortical cell cultures obtained from pups exposed to WIN during gestation with respect to those measured in cultures obtained from neonates born from vehicle-treated dams. The addition of NMDA to cortical cell cultures from neonates born from vehicle-treated dams concentration-…

MaleMarijuana AbuseCannabinoid receptoractive avoidance behaviour; basal and K+-evoked glutamate levels; cortical cell cultures; homing behaviour; maternal marijuana consumption; ultrasonic vocalizationEmotionsReceptor Cannabinoid CB1Pregnancyactive avoidance behaviourWIN 55212-2Cells CulturedCerebral CortexBehavior AnimalGlutamate receptorBraincortical cell culturesCalcium Channel Blockersactive avoidance behaviour; basal and k plus -evoked glutamate levels; basal and k+-evoked glutamate levels; cortical cell cultures; homing behaviour; maternal marijuana consumption; ultrasonic vocalizationPrenatal Exposure Delayed EffectsChloratesNMDA receptorbasal and K+-evoked glutamate levelsFemaleMicrotubule-Associated Proteinsmedicine.drugAgonistmedicine.medical_specialtyOffspringmedicine.drug_classCognitive NeuroscienceMorpholinesGlutamic Acidmaternal marijuana consumptionNeurotransmissionBiologyNaphthalenesReceptors N-Methyl-D-AspartateCellular and Molecular NeuroscienceGlutamatergicInternal medicinemedicineAvoidance LearningAnimalsRats WistarBenzoxazinesRatsultrasonic vocalizationEndocrinologyAnimals Newbornhoming behaviourVocalization AnimalExtracellular SpaceNeuroscience
researchProduct

Is physical activity associated with low-risk health behaviours among 15-year-old adolescents in Finland?

2012

Aims: To investigate the associations between physical activity and the pattern of risk health behaviour consisting of smoking, alcohol consumption, snuff (snus), cannabis, and condom use among 15-year-old adolescents, taking their educational aspirations and family affluence into account. Methods: The data were collected in the Health Behaviour in School-aged Children (HBSC) study in Finland in 2006. Standardised questionnaires were issued at schools to a 15-year-old nationally representative sample, of which 84.5% (1710 pupils) participated. Logistic regression analysis was used to explore the associations between physical activity, pattern of risk health behaviour, family affluence, and…

MaleMarijuana AbuseCross-sectional studyHealth Behaviorphysical activityfamily affluencelaw.inventionCondomsnuoretlawMedicineFinlandeducation.field_of_studybiologyexerciseSmokingAge Factorsta3141General MedicineTobacco Use Disorderriskitekijärisk factorSnusEducational StatusFemaleFamily Relationsmedicine.medical_specialtyTobacco SmokelessAlcohol DrinkingAdolescentPopulationMotor Activityterveyden edistäminenRisk-TakingSex FactorsCondomliikunta-aktiivisuusEnvironmental healthHumansSnuffRisk factorperheen koettu varallisuusPsychiatryeducationbusiness.industryPublic Health Environmental and Occupational Healthbiology.organism_classificationfyysinen harjoitteluHealth promotionCross-Sectional StudiesAdolescent BehaviorCannabisbusiness
researchProduct

The Maudsley Environmental Risk Score for Psychosis

2018

AbstractBackgroundRisk prediction algorithms have long been used in health research and practice (e.g. prediction of cardiovascular disease and diabetes). However, similar tools have not been developed for mental health. For example, for psychotic disorders, attempts to sum environmental risk are rare, unsystematic and dictated by available data. In light of this, we sought to develop a valid, easy to use measure of the aggregate environmental risk score (ERS) for psychotic disorders.MethodsWe reviewed the literature to identify well-replicated and validated environmental risk factors for psychosis that combine a significant effect and large-enough prevalence. Pooled estimates of relative r…

MaleMarijuana AbusePsychosisUrban PopulationPopulationEthnic groupDiseaseEnvironmentRisk AssessmentPaternal Agerisk prediction03 medical and health sciences0302 clinical medicineAdverse Childhood ExperiencesPregnancyRisk FactorsEnvironmental healthEthnicitymedicineHumanspsychosisRisk factoreducationMinority GroupsApplied Psychologyeducation.field_of_studybusiness.industryOriginal ArticlesOdds ratiomedicine.diseaseMental healthObstetric Labor Complications3. Good health030227 psychiatryschizophreniaPsychiatry and Mental healthPsychotic DisordersSchizophreniaRelative riskFemaleliabilitybusiness030217 neurology & neurosurgery
researchProduct

The contribution of cannabis use to variation in the incidence of psychotic disorder across Europe (EU-GEI): a multicentre case-control study.

2019

Background: Cannabis use is associated with increased risk of later psychotic disorder but whether it affects incidence of the disorder remains unclear. We aimed to identify patterns of cannabis use with the strongest effect on odds of psychotic disorder across Europe and explore whether differences in such patterns contribute to variations in the incidence rates of psychotic disorder. Methods: We included patients aged 18–64 years who presented to psychiatric services in 11 sites across Europe and Brazil with first-episode psychosis and recruited controls representative of the local populations. We applied adjusted logistic regression models to the data to estimate which patterns of canna…

MaleMarijuana Abusecannabis psychosis first episode psychosis incidenceENGLANDHIGH-POTENCY CANNABIS0302 clinical medicineSCHIZOPHRENIAOdds RatioMedicine030212 general & internal medicinepsychosisSalut mentalRISKeducation.field_of_studybiologyIncidence (epidemiology)IncidenceArticlesASSOCIATIONMiddle Aged3. Good healthEuropePsychiatry and Mental healthPUBLIC-HEALTHFemaleCase-Control StudieBrazilHumanAdultmedicine.medical_specialtyPsychosisPopulationPsychotic DisorderOdds03 medical and health sciencesYoung Adultfirst episode psychosisJournal ArticleHumanseducationSettore MED/25 - PsichiatriaBiological PsychiatryCannabisbusiness.industryLONDONPublic healthCase-control studyOdds ratiobiology.organism_classificationmedicine.diseaseTRENDS030227 psychiatryPsychotic DisordersMARIJUANACase-Control StudiesCannabisDroguesbusinessDemography
researchProduct